CN105687799A - Traditional Chinese medicine composition for treating epilepsy - Google Patents
Traditional Chinese medicine composition for treating epilepsy Download PDFInfo
- Publication number
- CN105687799A CN105687799A CN201610175229.8A CN201610175229A CN105687799A CN 105687799 A CN105687799 A CN 105687799A CN 201610175229 A CN201610175229 A CN 201610175229A CN 105687799 A CN105687799 A CN 105687799A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- epilepsy
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention discloses a traditional Chinese medicine composition for treating epilepsy. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10 to 30 parts of seeds of Chinese dodder, 10 to 20 parts of arisaema cum bile, 5 to 15 parts of rhizoma gastrodiae, 10 to 20 parts of tortoise plastron, 10 to 20 parts of concha mauritiae, 10 to 20 parts of cortex mori radicis, 10 to 20 parts of human placenta, 5 to 15 parts of bezoar, 10 to 20 parts of Japanese ardisia herb, 10 to 20 parts of spina gleditsiae, 5 to 15 parts of antelope's horn, 10 to 20 parts of oeder plagiopus herb, 10 to 30 parts of magnetite, 5 to 15 parts of batryticated silkworm, 10 to 20 parts of flower of Chinese scholartree, 10 to 20 parts of panax quinquefolium, 10 to 20 parts of cairo morningglory roots or leaves, 5 to 15 parts of virginia grape fern herb with roots, 10 to 20 parts of haematitum, 10 to 20 parts of amber, 5 to 15 parts of rhizoma arisaematis, 10 to 20 parts of motherwort fruit and 5 to 15 parts of liquorice roots. The traditional Chinese medicine composition has the efficacy of relieving epilepsy and dizziness, calming the liver, clearing the fire, eliminating phlegm to enlighten the brain, activating the blood and dispersing blood stasis; the epilepsy treating effect is obvious; the effect is reliable.
Description
Technical field
The present invention relates to the medicinal preparation not determining structure of a kind of traditional herbal medicines, especially a kind of Chinese medicine composition treating epilepsy。
Background technology
Epilepsy, is commonly called as " epilepsy " or " epilepsy ", is the electric discharge of cerebral neuron paroxysmal abnormality, causes a kind of chronic disease of of short duration cerebral disorder。It is one of nervous system common disease, and prevalence is only second to apoplexy, shows as and breaks out, and automatically terminates, the obstacle of recurrent sensation of movement, spirit and consciousness aspect。Common because have: Family genetic factors, brain injury, viral infection and environmental effect are all the factors causing epileptic condition。Patient's body and mind often can be caused very big injury by the generation of epileptic condition, should and prevent and treat。Epilepsy class Western medicine is taken in treatment currently for epileptics mostly, but this type of medicine can only recur by symptom management, and health can be had side effects by prolonged administration of drugs。
It is trouble by wind, fire, expectorant, the stasis of blood that the traditional Chinese medical science thinks that epilepsy is, causes that the heart, liver,spleen,kidney, visceral-qi are lacked of proper care, the hepatic and renal YIN deficiency, and knot in sputum, painstaking effort are unsuccessful and the stasis of blood, cause epilepsy eventually。
According to theory of Chinese medical science, for the pathogeny of epilepsy, to determine epilepsy and relieve dizziness, high fever, infantile convulsions, epilepsy, etc., suppressing the hyperactive liver pathogenic fire purging, eliminate the phlegm have one's ideas straightened out, blood circulation promoting and blood stasis dispelling for the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease。
Summary of the invention
In order to overcome the epilepsy class medicine of existing treatment epilepsy exist can only symptom management, deficiency that side effect is big, the present invention provide a kind of prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, the Chinese medicine composition for the treatment of epilepsy that has no side effect。
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating epilepsy, it is characterized in that: its raw material of Chinese medicine and weight be: Semen Cuscutae 10-30 part, Arisaema Cum Bile 10-20 part, Rhizoma Gastrodiae 5-15 part, Carapax et Plastrum Testudinis 10-20 part, Concha Erosariae seu Cypraeae 10-20 part, Cortex Mori 10-20 part, Placenta Hominis 10-20 part, Calculus Bovis 5-15 part, Herba Ardisiae Japonicae 10-20 part, Spina Gleditsiae 10-20 part, Cornu Saigae Tataricae 5-15 part, Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 10-20 part, Magnetitum 10-30 part, Bombyx Batryticatus 5-15 part, Flos Sophorae 10-20 part, Radix Panacis Quinquefolii 10-20 part, Herba Ipomoeae Cairicae 10-20 part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5-15 part, Haematitum 10-20 part, succinum 10-20 part, Rhizoma Arisaematis 5-15 part, Fructus Leonuri 10-20 part, Radix Glycyrrhizae 5-15 part。
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating epilepsy, it is characterised in that: its raw material of Chinese medicine and weight be: Semen Cuscutae 20 parts, Arisaema Cum Bile 15 parts; 10 parts of Rhizoma Gastrodiae, Carapax et Plastrum Testudinis 15 parts, Concha Erosariae seu Cypraeae 15 parts; Cortex Mori 15 parts, Placenta Hominis 15 parts, Calculus Bovis 10 parts; Herba Ardisiae Japonicae 15 parts, Spina Gleditsiae 15 parts, Cornu Saigae Tataricae 10 parts; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 15 parts; Magnetitum 20 parts, Bombyx Batryticatus 10 parts, 15 parts of Flos Sophorae; Radix Panacis Quinquefolii 15 parts; Herba Ipomoeae Cairicae 15 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 10 parts, Haematitum 15 parts; succinum 15 parts; Rhizoma Arisaematis 10 parts, Fructus Leonuri 15 parts, 10 parts of Radix Glycyrrhizae。
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription。In Chinese medicine composition of the present invention: Semen Cuscutae has effect of the kidney invigorating and essence nourishing, nourishing the liver spleen invigorating;Arisaema Cum Bile has effect of removing heat-phlegm, dispelling wind and relieving convulsion;Rhizoma Gastrodiae has effect of endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral;Carapax et Plastrum Testudinis has effect of nourishing kidney YANG hyperactivity suppressing, replenishing kidney and strengthening bone, reinforcing the heart of nourishing blood;Concha Erosariae seu Cypraeae has suppressing the hyperactive liver and subsiding YANG, tranquillizing the mind by relieving convulsion, liver heat removing and eyesight improving;Cortex Mori has effect of eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema;Placenta Hominis has effect of the kidney invigorating and essence nourishing, benefiting QI and nourishing blood;Calculus Bovis has effect of heat-clearing and toxic substances removing, cool liver endogenous wind stopping;Herba Ardisiae Japonicae has preventing phlegm from forming and stopping coughing, dampness removing, effect of invigorating blood circulation;Spina Gleditsiae has evacuation of pus of drawing out pus by applying a plaster to the affected part, promoting blood circulation and detumescence, goes effect of air slaking expectorant;Cornu Saigae Tataricae has effect of suppressing the hyperactive liver to relieve the wind syndrome, liver heat removing and eyesight improving, removing pathogenic heat from blood and toxic substance from the body;Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) has effect of tranquillizing and allaying excitement;Magnetitum has suppressing the hyperactive liver and subsiding YANG, effect relieving convulsion, hearing-improing and eyesight improving, helping inspiration to relieve asthma of calming the nerves;Bombyx Batryticatus has effect of expelling wind for relieving convulsion, dissipating phlegm and resolving masses;Flos Sophorae has effect of cooling blood for hemostasis, purging liver-fire;Radix Panacis Quinquefolii has effect of boosting qi and nourishing yin, clearing away heat and promoting production of body fluid;Herba Ipomoeae Cairicae has effect of clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling;Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. has effect of heat-clearing and toxic substances removing, suppressing the hyperactive liver eliminating stagnation, expelling wind for relieving convulsion;Haematitum has effect of suppressing the hyperactive liver and subsiding YANG, sending down the abnormal ascending QI hemostasis;Succinum has effect of tranquillizing the mind by relieving convulsion, dissipating blood stasis hemostasis, relieving stranguria by diuresis;Rhizoma Arisaematis has drying dampness to eliminate phlegm, effect of expelling wind to relieve convulsion;Fructus Leonuri has effect of promoting blood flow to regulate menstruation, liver heat removing and eyesight improving;Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription。Drug component in the present composition, through dialectical compatibility, complements each other using, and has synergism, play altogether determine epilepsy relieve dizziness, high fever, infantile convulsions, epilepsy, etc., suppressing the hyperactive liver pathogenic fire purging, eliminate the phlegm have one's ideas straightened out, effect of blood circulation promoting and blood stasis dispelling, epilepsy is reached the purpose for the treatment of both the principal and secondary aspects of a disease。
The component of the present composition all adopts natural raw material of Chinese medicine, and preparation is easy, medicine source is wide, cost is low for it。It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose。Verifying by clinic application, it is evident in efficacy, reliable effect, mild in medicine property and, toxic and side effects does not occur, total effective rate 82%, cure rate reaches 34.8%。
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described。
Embodiment 1
A kind of Chinese medicine composition treating epilepsy, its raw material of Chinese medicine and weight proportion be: Semen Cuscutae 20g, Arisaema Cum Bile 15g, Rhizoma Gastrodiae 10g; Carapax et Plastrum Testudinis 15g, Concha Erosariae seu Cypraeae 15g, Cortex Mori 15g, Placenta Hominis 15g; Calculus Bovis 10g, Herba Ardisiae Japonicae 15g, Spina Gleditsiae 15g, Cornu Saigae Tataricae 10g; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 15g, Magnetitum 20g, Bombyx Batryticatus 10g, Flos Sophorae 15g; Radix Panacis Quinquefolii 15g, Herba Ipomoeae Cairicae 15g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 10g, Haematitum 15g; succinum 15g, Rhizoma Arisaematis 10g, Fructus Leonuri 15g, Radix Glycyrrhizae 10g。
Embodiment 2
A kind of Chinese medicine composition treating epilepsy, its raw material of Chinese medicine and weight proportion be: Semen Cuscutae 30g, Arisaema Cum Bile 10g, Rhizoma Gastrodiae 15g; Carapax et Plastrum Testudinis 10g, Concha Erosariae seu Cypraeae 20g, Cortex Mori 10g, Placenta Hominis 20g; Calculus Bovis 5g, Herba Ardisiae Japonicae 20g, Spina Gleditsiae 10g, Cornu Saigae Tataricae 15g; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 10g, Magnetitum 30g, Bombyx Batryticatus 5g, Flos Sophorae 20g; Radix Panacis Quinquefolii 10g, Herba Ipomoeae Cairicae 20g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5g, Haematitum 20g; succinum 10g, Rhizoma Arisaematis 15g, Fructus Leonuri 10g, Radix Glycyrrhizae 15g。
Embodiment 3
A kind of Chinese medicine composition treating epilepsy, its raw material of Chinese medicine and weight proportion be: Semen Cuscutae 10g, Arisaema Cum Bile 20g, Rhizoma Gastrodiae 5g; Carapax et Plastrum Testudinis 20g, Concha Erosariae seu Cypraeae 10g, Cortex Mori 20g, Placenta Hominis 10g; Calculus Bovis 15g, Herba Ardisiae Japonicae 10g, Spina Gleditsiae 20g, Cornu Saigae Tataricae 5g; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 20g, Magnetitum 10g, Bombyx Batryticatus 15g, Flos Sophorae 10g; Radix Panacis Quinquefolii 20g, Herba Ipomoeae Cairicae 10g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 15g, Haematitum 10g; succinum 20g, Rhizoma Arisaematis 5g, Fructus Leonuri 20g, Radix Glycyrrhizae 5g。
Embodiment 4
A kind of Chinese medicine composition treating epilepsy, its raw material of Chinese medicine and weight proportion be: Semen Cuscutae 23g, Arisaema Cum Bile 12g, Rhizoma Gastrodiae 13g; Carapax et Plastrum Testudinis 12g, Concha Erosariae seu Cypraeae 17g, Cortex Mori 13g, Placenta Hominis 17g; Calculus Bovis 7g, Herba Ardisiae Japonicae 17g, Spina Gleditsiae 12g, Cornu Saigae Tataricae 13g; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 12g, Magnetitum 23g, Bombyx Batryticatus 7g, Flos Sophorae 17g; Radix Panacis Quinquefolii 12g, Herba Ipomoeae Cairicae 17g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 7g, Haematitum 17g; succinum 13g, Rhizoma Arisaematis 13g, Fructus Leonuri 12g, Radix Glycyrrhizae 13g。
Embodiment 5
A kind of Chinese medicine composition treating epilepsy, its raw material of Chinese medicine and weight proportion be: Semen Cuscutae 18g, Arisaema Cum Bile 18g, Rhizoma Gastrodiae 7g; Carapax et Plastrum Testudinis 18g, Concha Erosariae seu Cypraeae 12g, Cortex Mori 18g, Placenta Hominis 12g; Calculus Bovis 13g, Herba Ardisiae Japonicae 12g, Spina Gleditsiae 18g, Cornu Saigae Tataricae 7g; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 18g, Magnetitum 18g, Bombyx Batryticatus 12g, Flos Sophorae 13g; Radix Panacis Quinquefolii 18g, Herba Ipomoeae Cairicae 12g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 13g, Haematitum 12g; succinum 18g, Rhizoma Arisaematis 7g, Fructus Leonuri 18g, Radix Glycyrrhizae 7g。
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament。Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15~20 minutes, adds water and do not have powder about 6 centimetres, carries out first time decoction, adopts intense fire to decoct before at a simmer, with slow fire boiling 20~30 minutes after boiling;Second time decocts, and adds water and did not have powder about 6 centimetres, and water decocts 15~20 minutes after boiling。Twice decoction is removed slag extracting juice, merges。
The present invention, with a kind of Chinese medicine composition treating epilepsy given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case 89 example, wherein male 42 examples, female 47 example, 20~65 years old age。
Two, diagnostic criteria:
1, faint suddenly during Generalized seizure, stiffness of the nape and back, tic of the limbs。Or only two orders are outfaced, that exhales does not answer, or nose drop, and limb is soft unable;
2, visible various ways during partial seizures, as mouth, eye, Shou Deng local tic and without fainting suddenly, or photis, or vomiting, hyperhidrosis, or speech disorder are, or unconscious action etc.;
3, onset is hurried, such as ordinary person, recurrent exerbation after waking up;
4, there is family history, often because terrified, fatigue, emotional stress etc. are brought out more;
5, often there are dizziness, the tendency such as uncomfortable in chest before outbreak;
6, EEG (electrocardiogram) examination has positive performance, has ready conditions and does CT, magnetic resonance examination;
7 it should be noted that differentiate with apoplexy, faint card, convulsive diseases etc.。
Three, usage and dosage: during clinical practice, one day potion, twice extracting juice of decocting is about 500ml, and point early, middle and late three warms are taken, and within seven days, are a course for the treatment of。
Four, criterion of therapeutical effect:
1, cure: compare with the outbreak intermittent time before treatment, extend and do not send out author in more than 1 year;
2, take a turn for the better: during outbreak, symptom alleviates than before, and the intermission is obviously prolonged;
3, do not heal: outbreak is frequent, or exacerbation of symptoms。
Five, therapeutic effect: in this clinical observation case, take medicine 5-12 the course for the treatment of, cure 31 examples, take a turn for the better 42 examples, and do not heal 16 examples。Toxic and side effects is there is not during treatment。
Six, model case:
Case 1: Wang, man, 50 years old。Readme when going to a doctor: before examining, in sleep, burst lower limb are tetanic, companion's left upper extremity is not independently shaken, it is not intended to knowledge two is just abnormal, without getting injured by a fall and biting, within about three minutes, alleviates。Rear above-mentioned symptom recurrent exerbation 3 times, interictal is as usual。Diagnosis is: epilepsy。After 5 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, during conscious outbreak, symptom alleviates than before, and frequency of disease development reduces;Continue to take 5 courses for the treatment of, transference cure, cure。
Case 2: money, female, 27 years old。Readme: without the obvious cause double; two upper limb fast jitter of burst before 2 years, in electric shock sample, the time, less than 1 second, can show effect continuously, and seizure frequency is 4-5 times/day, diagnoses and is: epilepsy。Once carbamazepine treatment, less effective were given。Taking 5 courses for the treatment of of medicament prepared by the Chinese medicine composition of the present invention, disease significantly alleviates, and seizure frequency reduces。Continue after taking 4 courses for the treatment of, each transference cure, cure。Follow up a case by regular visits to half a year without recurrence。
Claims (2)
1. the Chinese medicine composition treating epilepsy, it is characterized in that: its raw material of Chinese medicine and weight be: Semen Cuscutae 10-30 part, Arisaema Cum Bile 10-20 part, Rhizoma Gastrodiae 5-15 part, Carapax et Plastrum Testudinis 10-20 part, Concha Erosariae seu Cypraeae 10-20 part, Cortex Mori 10-20 part, Placenta Hominis 10-20 part, Calculus Bovis 5-15 part, Herba Ardisiae Japonicae 10-20 part, Spina Gleditsiae 10-20 part, Cornu Saigae Tataricae 5-15 part, Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 10-20 part, Magnetitum 10-30 part, Bombyx Batryticatus 5-15 part, Flos Sophorae 10-20 part, Radix Panacis Quinquefolii 10-20 part, Herba Ipomoeae Cairicae 10-20 part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5-15 part, Haematitum 10-20 part, succinum 10-20 part, Rhizoma Arisaematis 5-15 part, Fructus Leonuri 10-20 part, Radix Glycyrrhizae 5-15 part。
2. a kind of Chinese medicine composition treating epilepsy according to claim 1, it is characterised in that: its raw material of Chinese medicine and weight be: Semen Cuscutae 20 parts, Arisaema Cum Bile 15 parts; 10 parts of Rhizoma Gastrodiae, Carapax et Plastrum Testudinis 15 parts, Concha Erosariae seu Cypraeae 15 parts; Cortex Mori 15 parts, Placenta Hominis 15 parts, Calculus Bovis 10 parts; Herba Ardisiae Japonicae 15 parts, Spina Gleditsiae 15 parts, Cornu Saigae Tataricae 10 parts; Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 15 parts; Magnetitum 20 parts, Bombyx Batryticatus 10 parts, 15 parts of Flos Sophorae; Radix Panacis Quinquefolii 15 parts; Herba Ipomoeae Cairicae 15 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 10 parts, Haematitum 15 parts; succinum 15 parts; Rhizoma Arisaematis 10 parts, Fructus Leonuri 15 parts, 10 parts of Radix Glycyrrhizae。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610175229.8A CN105687799A (en) | 2016-03-25 | 2016-03-25 | Traditional Chinese medicine composition for treating epilepsy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610175229.8A CN105687799A (en) | 2016-03-25 | 2016-03-25 | Traditional Chinese medicine composition for treating epilepsy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105687799A true CN105687799A (en) | 2016-06-22 |
Family
ID=56232794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610175229.8A Pending CN105687799A (en) | 2016-03-25 | 2016-03-25 | Traditional Chinese medicine composition for treating epilepsy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105687799A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106109785A (en) * | 2016-08-11 | 2016-11-16 | 徐西春 | A kind of Chinese medicine composition treating children epilepsy |
-
2016
- 2016-03-25 CN CN201610175229.8A patent/CN105687799A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106109785A (en) * | 2016-08-11 | 2016-11-16 | 徐西春 | A kind of Chinese medicine composition treating children epilepsy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698092A (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
CN101045137A (en) | Capsule for treating epilepsia and its preparing method | |
CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
CN105833003A (en) | Traditional Chinese medicine composition for treating autism | |
CN102258703B (en) | Traditional Chinese medicine for treating vertigo | |
CN105687799A (en) | Traditional Chinese medicine composition for treating epilepsy | |
CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
CN103860914A (en) | Chinese medicine composition for treating epilepsy | |
CN104758652A (en) | Traditional Chinese medicine composition for treating dizziness | |
CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
CN104474173B (en) | A kind of medicine for treating facioplegia | |
CN103386080B (en) | Medicine composite for curing combined external head injuries in clinical nursing | |
CN103285108B (en) | Chinese medicinal composition treating lumbago | |
CN103251701B (en) | Traditional Chinese medicine composition for treating rhinitis | |
CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
CN104623333A (en) | Drug for treating facial paralysis | |
CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
CN105770427A (en) | Traditional Chinese medicine composition for treating oligospermia and asthenozoospermia | |
CN105079514A (en) | Traditional Chinese medicine composition for treating dizziness | |
CN105288229A (en) | Traditional Chinese medicine composition for treating nystagmus | |
CN104587397A (en) | Traditional Chinese medicinal composition for treating endocrine dyscrasia | |
CN104324164A (en) | Traditional Chinese medicine composition for nursing of cerebral concussion sequelae | |
CN107050144A (en) | A kind of Chinese medicine for treating traumatic injury | |
CN105797088A (en) | Traditional Chinese medicinal composition for treating anxiety |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160622 |